Interviews with the world’s key opinion leaders in cancer

TagASCO GU 2014 Symposium San Francisco

AJO Oncology Video

Initial Gleason score does not predict abiraterone response in patients with metastatic castration-resistant prostate cancer

February 12, 2014

SAN FRANCISCO— Gleason score at initial diagnosis was not predictive of response to abiraterone in patients with metastatic castration-resistant...